Table 2.
H58 lineage | H58 subgroup | Nalidixic acid | GyrA SNP | Treatment | N1 |
---|---|---|---|---|---|
II | G | resistant | Phe83 | inpatient | 30 |
II | G | resistant | Phe83 | outpatient | 11 |
II | G* | resistant | Phe83 | outpatient | 1 |
I | B | sensitive | wildtype | inpatient | 1 |
H58 lineage | H58 subgroup | Nalidixic acid | GyrA SNP | Treatment | N1 |
---|---|---|---|---|---|
II | G | resistant | Phe83 | inpatient | 30 |
II | G | resistant | Phe83 | outpatient | 11 |
II | G* | resistant | Phe83 | outpatient | 1 |
I | B | sensitive | wildtype | inpatient | 1 |